Debt to Equity Ratio Chart

View Debt to Equity Ratio for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 2.264
March 31, 2026 1.881
December 31, 2025 1.586
September 30, 2025 1.553
June 30, 2025 1.198
March 31, 2025 3.660
December 31, 2024 2.449
September 30, 2024 1.830
June 30, 2024 1.358
March 31, 2024 1.174
December 31, 2023 1.045
September 30, 2023 0.9001
June 30, 2023 0.7847
March 31, 2023 0.9817
December 31, 2022 0.849
September 30, 2022 0.6316
June 30, 2022 0.5618
March 31, 2022 0.4625
December 31, 2021 0.3304
September 30, 2021 0.307
June 30, 2021 0.2866
March 31, 2021 0.2686
Date Value
December 31, 2020 0.6445
September 30, 2020 0.6009
June 30, 2020 0.5537
March 31, 2020 0.5202
December 31, 2019 0.4688
September 30, 2019 0.4409
June 30, 2019 -37.46
March 31, 2019 -8.997
December 31, 2018 -4.448
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2015 -1.190
September 30, 2015 -1.254
June 30, 2015 -1.325
March 31, 2015 -1.303
December 31, 2014 -1.461
September 30, 2014 -1.691
June 30, 2014 -2.181
March 31, 2014
December 31, 2013 22.17

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Myriad Genetics, Inc. 0.6927
BioRestorative Therapies, Inc. 0.0114
CareDx, Inc. 0.0452
Natera, Inc. 0.1309
Sera Prognostics, Inc. 0.0505